G. Arslan Et Al. , "Therapeutic Use of Bone Marrow-Derived Tolerogenic Dendritic Cells Modified bu Lentiviral Transduction in C57BL/6 EAE Model," 5th International Molecular Immunology and Immunogenetics Congress (MIMIC V) , 2022
Arslan, G. Et Al. 2022. Therapeutic Use of Bone Marrow-Derived Tolerogenic Dendritic Cells Modified bu Lentiviral Transduction in C57BL/6 EAE Model. 5th International Molecular Immunology and Immunogenetics Congress (MIMIC V) .
Arslan, G., Karaçay, M., ÇELİK, E., GÜVENÇ BAYRAM, G., Yumusak, E., dündar, f., ... YÖYEN ERMİŞ, D.(2022). Therapeutic Use of Bone Marrow-Derived Tolerogenic Dendritic Cells Modified bu Lentiviral Transduction in C57BL/6 EAE Model . 5th International Molecular Immunology and Immunogenetics Congress (MIMIC V)
Arslan, Gözde Et Al. "Therapeutic Use of Bone Marrow-Derived Tolerogenic Dendritic Cells Modified bu Lentiviral Transduction in C57BL/6 EAE Model," 5th International Molecular Immunology and Immunogenetics Congress (MIMIC V), 2022
Arslan, Gözde Et Al. "Therapeutic Use of Bone Marrow-Derived Tolerogenic Dendritic Cells Modified bu Lentiviral Transduction in C57BL/6 EAE Model." 5th International Molecular Immunology and Immunogenetics Congress (MIMIC V) , 2022
Arslan, G. Et Al. (2022) . "Therapeutic Use of Bone Marrow-Derived Tolerogenic Dendritic Cells Modified bu Lentiviral Transduction in C57BL/6 EAE Model." 5th International Molecular Immunology and Immunogenetics Congress (MIMIC V) .
@conferencepaper{conferencepaper, author={Gözde Arslan Et Al. }, title={Therapeutic Use of Bone Marrow-Derived Tolerogenic Dendritic Cells Modified bu Lentiviral Transduction in C57BL/6 EAE Model}, congress name={5th International Molecular Immunology and Immunogenetics Congress (MIMIC V)}, city={}, country={}, year={2022}}